|
UBR5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.340100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.364110E-02 |
| Normal-vs-Stage2 |
8.803700E-02 |
| Normal-vs-Stage3 |
3.623800E-03 |
| Normal-vs-Stage4 |
6.383500E-03 |
| Stage1-vs-Stage2 |
9.158200E-01 |
| Stage1-vs-Stage3 |
2.867000E-01 |
| Stage1-vs-Stage4 |
3.068800E-01 |
| Stage2-vs-Stage3 |
6.074800E-01 |
| Stage2-vs-Stage4 |
5.678000E-01 |
| Stage3-vs-Stage4 |
9.332600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.317470E-03 |
| Normal-vs-AfricanAmerican |
2.232400E-01 |
| Normal-vs-Asian |
6.316800E-01 |
| Caucasian-vs-AfricanAmerican |
2.341800E-01 |
| Caucasian-vs-Asian |
8.963800E-02 |
| AfricanAmerican-vs-Asian |
3.164400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.177100E-04 |
| Normal-vs-Female |
1.570430E-01 |
| Male-vs-Female |
3.776600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.611800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.037800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.478330E-03 |
| Normal-vs-Age(81-100Yrs) |
3.947800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.088000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.615800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.191200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.223000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.087200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.364800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.869000E-01 |
| Normal-vs-Grade 2 |
1.353390E-01 |
| Normal-vs-Grade 3 |
1.152160E-04 |
| Normal-vs-Grade 4 |
8.700100E-03 |
| Grade 1-vs-Grade 2 |
7.256100E-02 |
| Grade 1-vs-Grade 3 |
7.60770000000077E-05 |
| Grade 1-vs-Grade 4 |
1.033940E-02 |
| Grade 2-vs-Grade 3 |
3.375900E-04 |
| Grade 2-vs-Grade 4 |
9.108500E-02 |
| Grade 3-vs-Grade 4 |
5.398000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.643600E-02 |
| Normal-vs-ccB subtype |
7.621000E-03 |
| ccA subtype-vs-ccB subtype |
1.646970E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.050460E-02 |
| Normal-vs-N1 |
8.241800E-02 |
| N0-vs-N1 |
6.239800E-01 |
|
|
